期刊文献+

Inhibition of Dual Specific Oncolytic Adenovirus on Esophageal Cancer via Activation of Caspases by a Mitochondrial-dependent Pathway 被引量:38

Inhibition of Dual Specific Oncolytic Adenovirus on Esophageal Cancer via Activation of Caspases by a Mitochondrial-dependent Pathway
下载PDF
导出
摘要 We investigated the anti-tumor effects of dual cancer specific-oncolytic adenovirus Ad-VP on esophageal cancer(EC). The anti-tumor activity of Ad-VP was compared with that of the control recombinant adenoviruses (Ad-GP, Ad-Apoptin, Ad-EGFP) in human esophageal cancer cell EC-109 and human normal liver cell L02 in vitro. In 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT) assays, the growth of EC-109 cells was slightly inhibited by Ad-GP, Ad-Apoptin and Ad-EGFE However, Ad-VP induced a significant cytotoxic effect. Infection of EC-109 cells with Ad-VP resulted in a significant induction of apoptosis of them in vitro, detected by 4',6-diamidino-2-phenylindole(DAPI) or acridine orange and ethidium bromide staining. The results of Western blot and flow cytometric assay indicate the loss of mitochondrial membrane potential(Aψm), the release of eytochrome c and the activation of caspase-3, 6 and 7 in Ad-VP infected EC-109 cells. In contrast, all these assays show almost no effects of the recombinant adenoviruses on L02 cells. These results demonstrate that the treatment of tumors with Ad-VP selectively inhibits tumor growth and induces apoptosis of esophageal cancer cells. Ad-VP may provide a novel and powerful strategy for cancer gene therapy. We investigated the anti-tumor effects of dual cancer specific-oncolytic adenovirus Ad-VP on esophageal cancer(EC). The anti-tumor activity of Ad-VP was compared with that of the control recombinant adenoviruses (Ad-GP, Ad-Apoptin, Ad-EGFP) in human esophageal cancer cell EC-109 and human normal liver cell L02 in vitro. In 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT) assays, the growth of EC-109 cells was slightly inhibited by Ad-GP, Ad-Apoptin and Ad-EGFE However, Ad-VP induced a significant cytotoxic effect. Infection of EC-109 cells with Ad-VP resulted in a significant induction of apoptosis of them in vitro, detected by 4',6-diamidino-2-phenylindole(DAPI) or acridine orange and ethidium bromide staining. The results of Western blot and flow cytometric assay indicate the loss of mitochondrial membrane potential(Aψm), the release of eytochrome c and the activation of caspase-3, 6 and 7 in Ad-VP infected EC-109 cells. In contrast, all these assays show almost no effects of the recombinant adenoviruses on L02 cells. These results demonstrate that the treatment of tumors with Ad-VP selectively inhibits tumor growth and induces apoptosis of esophageal cancer cells. Ad-VP may provide a novel and powerful strategy for cancer gene therapy.
出处 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2012年第3期465-471,共7页 高等学校化学研究(英文版)
基金 Supported by the Genetically Modified Organisms Breeding Major Project of China(No.2009ZX08006-002B) the National Natural Science Foundation of China(Nos.81101140,81072210) the Key Technologies Research and Development Program of Jilin Province,China(Nos.10ZDGG007,201015166) the China Postdoctoral Science Foundation Funded Project(No.20100481057)
关键词 APOPTIN Apoptosis ANTI-TUMOR Esophageal cancer Recombinant adenovirus Apoptin Apoptosis Anti-tumor Esophageal cancer Recombinant adenovirus
  • 相关文献

参考文献25

  • 1Kollarova H., Machova L., Horakova D., Janoutova G., Janout V., Biomed. Pap. Med, Fac. Univ. Palacky. Olomouc. Czech. Repub., 2007, 151(1), 17.
  • 2Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M. J., CA Cancer J. Clin., 2009, 59, 225.
  • 3Vaha-Koskela M. J., Heikkila J. E., Hinkkanen A. E., Cancer Lett., 2007, 254, 178.
  • 4Li X., Liu Y., Wen Z. M., Li C., Lu H. L, Tian M. Y., Jin K. S., Sun L. L., Gao P., Yang E. C., Xu X. H. Kan S. F., Wang Z. Y., Wang Y. H., Jin N. Y., Mol. Cancer, 2010, 9, 10.
  • 5Hu W., Kavanagh J. J., Lancet Oneol., 2003, 4, 721.
  • 6Li X., Jin N. Y., Li C., Tian M. Y., Chen L., Jia P., Liu L. M., Liu Y., Gao P., Chem. J. Chinese Universities, 2009, 30(4), 682.
  • 7Oro C., Jans D. A., Curr. Drug Targets, 2004, 5, 179.
  • 8Pooh I. K., Oro C., Dias M. M., Zhang J., Jans D. A., Cancer Res., 2005, 65, 7059.
  • 9Maddika S., Mendoza F. J., Hauff K., Zamzow C. R., Paranjothy T., Los M., Cancer Biol. Ther., 2006, 5(1), 10.
  • 10Huang S. M., Shvarts A., van Ormondt H., Jochemsen A. G., van der Eb A. L, Notebom M. H., Cancer Res., 1995, 55, 486.

同被引文献168

引证文献38

二级引证文献458

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部